More significant changes in thickness and density are typically seen after 36 months of consistent use
It combines three well-studied peptidesGHK-Cu, BPC-157, and TB500into a single laboratory-grade blend designed for controlled experimental applications
Angiogenesis, wound-repair, and preclinical systemic effects In preclinical models, GHK-Cu promotes angiogenesis (new blood-vessel formation), attracts repair cells such as macrophages and capillary cells to injury sites, and accelerates wound healing across a range of tissues and species skin, hair follicles, gastrointestinal lining, bone, and more
This opens new avenues for therapy, potentially restoring the effectiveness of existing treatments